ISEMBYLD
associated with 9 other trademarks
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therap...

Words that describe this trademark:

Serial Number:

97723538

Mark:

ISEMBYLD

Status:

Second Extension-Granted

Status Date:

10-25-2024

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

10-31-2023

Mark Drawing Status:

4

Abandon Date:

N/A

Business Name:

600 ATLANTIC AVENUE

Recent Trademark filings by this company